Ozanimod and Felbamate: Interaction Details
- Ozanimod
- ZeposiaZEPOSIA 7-Day Starter Pack
- Felbamate
- Felbatol
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Ozanimod and Felbamate interaction:
Ozanimod
- Zeposia
- ZEPOSIA 7-Day Starter Pack
What Happens When You Take Ozanimod With Felbamate
What can happen when they are taken together (rated Major)
effects on heart rate
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Ozanimod can cause a temporary reduction in heart rate as well as delays in atrioventricular conduction. No studies of ozanimod have been conducted in patients receiving QT prolonging drugs.
Because the effects on heart rate could be additive, ozanimod generally should not be started in patients already treated with QT prolonging drugs that have recognized arrhythmogenic properties. When is under consideration, advice should be sought from a cardiologist.1
The Ozanimod and Felbamate Interaction, Explained
Ozanimod (Zeposia), used for ulcerative colitis or multiple sclerosis, can slow your heart rate a little, mostly when you first start it, and can slow the electrical signals in the heart. Felbamate (Felbatol), a seizure medicine, is listed as a drug that may add to these heart rhythm effects. This concern is theoretical, meaning it is based on how the drugs work and not on proven problems in patients.
Because the risk is rated major, ozanimod is usually not started in people taking certain heart-rhythm-affecting drugs unless a heart specialist is involved. Keep taking both as prescribed and talk with your pharmacist or doctor. Your care team can manage this with a heart check and closer monitoring if needed.
Interaction: Potential effects on heart rate and conduction () between ozanimod and felbamate, which is listed here as a QT-prolonging agent.
- Mechanism: Ozanimod (S1P1/S1P5 modulator) can cause transient and AV conduction delay, particularly at initiation. Additive effects are possible with drugs affecting cardiac conduction or repolarization.
- Magnitude/onset: Not quantified; onset unspecified.
- Evidence: Theoretical. Ozanimod has not been studied with QT-prolonging drugs.
- Management: Generally avoid initiating ozanimod in patients on QT-prolonging drugs with known arrhythmogenic properties. If is considered, obtain cardiologist advice, and consider baseline and heart rate monitoring at initiation.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Ozanimod and Felbamate Interact
The likely mechanism
effects on heart rate
How to Manage the Ozanimod and Felbamate Interaction
Keep taking both medicines exactly as prescribed, and do not stop or change either one on your own.
- Tell your prescriber and pharmacist that you take felbamate before starting ozanimod, or if you are already on both.
- Your care team may involve a heart specialist (cardiologist) to decide whether the combination is appropriate.
- Your team may monitor your heart more closely, especially when ozanimod is started, and may tailor your treatment plan.
- Report dizziness, fainting, a very slow or irregular heartbeat, or chest discomfort promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Ozanimod or Felbamate need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Ozanimod and Felbamate: Common Questions
How serious is the Ozanimod and Felbamate interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Ozanimod and Felbamate interaction managed?
Keep taking both medicines exactly as prescribed, and do not stop or change either one on your own. Tell your prescriber and pharmacist that you take felbamate before starting ozanimod, or if you are already on both. Your care team may involve a heart specialist (cardiologist) to decide whether the combination is appropriate. Your team may monitor your heart more closely, especially when ozanimod… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Ozanimod and Felbamate Interaction
Ask in your own words about taking Ozanimod and Felbamate together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: ZEPOSIA(R) oral capsules, ozanimod oral capsules. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2024. DailyMed
Other Serious Interactions of Ozanimod and Felbamate
Also serious with Ozanimod
- Acetaminophen and CodeineContraindicated
- SertralineContraindicated
- Linezolid InjectionContraindicated
- MethyldopaContraindicated
Also serious with Felbamate
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Felbamate
- GrapefruitMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- American HelleboreMajor
- ArsenicMajor
- BeerMajor
- + 164 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.